Jason Luke, MD, assistant professor at the University of Chicago Medicine, discusses what he hopes the future of advanced melanoma treatment will look like.
With new agents and combinations, long-term melanoma survival will continue to improve. Luke hopes that the future landscape for advanced melanoma -- and all cancers -- will become similar to managing a chronic disease. To do this, there must be treatments with high efficacy and low toxicity profiles.
You must log in to use this feature, please click here to login.